Found 17 matching trials
A Study of GPC3 Redirected Autologous T Cells for Advanced HCC
PHASE1Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
PHASE1This phase I/II trial studies the side effects and best dose of genetically...
Location
Fred Hutch/University of Washington Cancer Consortium
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
PHASE1This pilot phase I trial studies the side effects of taking ipilimumab afte...
Location
Jonsson Comprehensive Cancer Center
Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs
N/AThis study will evaluate the safety of giving lymphocytes (white blood cell...
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells
PHASE1In the laboratory, we will put a special gene into cancer cells that have b...
Location
Multiple Locations
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
PHASE2The purpose of this phase 2 study is to find the best way to give this new ...
Location
University of California Los Angeles, David Geffen School of Medicine
TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)
PHASE1The study purpose is to establish the safety and tolerability of IMA201 in ...
Location
University of Pittsburgh Medical Center
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
PHASE1The goal of this Phase I/II observational and interventional platform study...
Location
Multiple Locations
Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
PHASE1The purpose of this study is to collect data on the safety and effectivenes...
Location
Tufts University Medical Center
CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
PHASE1The purpose of this study is to find out the safety and activity of an expe...
Location
Walter Reed Army Medical Center